1. Home
  2. ADX vs ARQT Comparison

ADX vs ARQT Comparison

Compare ADX & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adams Diversified Equity Fund Inc.

ADX

Adams Diversified Equity Fund Inc.

N/A

Current Price

$22.51

Market Cap

2.8B

Sector

Finance

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$24.48

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ADX
ARQT
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
ADX
ARQT
Price
$22.51
$24.48
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$31.86
AVG Volume (30 Days)
229.5K
1.2M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
N/A
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
N/A
$34.46
Revenue Next Year
N/A
$29.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
91.34
52 Week Low
$16.50
$11.86
52 Week High
$23.85
$31.77

Technical Indicators

Market Signals
Indicator
ADX
ARQT
Relative Strength Index (RSI) 36.84 42.68
Support Level $22.18 $22.26
Resistance Level $23.51 $27.65
Average True Range (ATR) 0.28 1.53
MACD -0.05 -0.25
Stochastic Oscillator 7.43 27.73

Price Performance

Historical Comparison
ADX
ARQT

About ADX Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: